- Home
- FIHL vs CERT Comparison
FIHL vs CERT Comparison
Compare FIHL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIHL
- CERT
- Stock Information
- Founded
- FIHL 2014
- CERT 2008
- Country
- FIHL Bermuda
- CERT United States
- Employees
- FIHL 77
- CERT N/A
- Industry
- FIHL
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- FIHL
- CERT Technology
- Exchange
- FIHL Nasdaq
- CERT Nasdaq
- Market Cap
- FIHL 1.8B
- CERT 2.1B
- IPO Year
- FIHL 2023
- CERT 2020
- Fundamental
- Price
- FIHL $16.50
- CERT $14.23
- Analyst Decision
- FIHL Buy
- CERT Buy
- Analyst Count
- FIHL 8
- CERT 7
- Target Price
- FIHL $20.88
- CERT $15.92
- AVG Volume (30 Days)
- FIHL 584.8K
- CERT 1.2M
- Earning Date
- FIHL 02-25-2025
- CERT 02-26-2025
- Dividend Yield
- FIHL 2.42%
- CERT N/A
- EPS Growth
- FIHL N/A
- CERT N/A
- EPS
- FIHL 3.96
- CERT N/A
- Revenue
- FIHL $2,299,900,000.00
- CERT $372,797,000.00
- Revenue This Year
- FIHL N/A
- CERT $10.28
- Revenue Next Year
- FIHL $13.72
- CERT $9.93
- P/E Ratio
- FIHL $4.17
- CERT N/A
- Revenue Growth
- FIHL N/A
- CERT 5.62
- 52 Week Low
- FIHL $12.43
- CERT $9.41
- 52 Week High
- FIHL $21.32
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- FIHL 38.62
- CERT 77.68
- Support Level
- FIHL $16.14
- CERT $13.19
- Resistance Level
- FIHL $17.11
- CERT $14.39
- Average True Range (ATR)
- FIHL 0.35
- CERT 0.66
- MACD
- FIHL 0.10
- CERT 0.23
- Stochastic Oscillator
- FIHL 48.74
- CERT 95.93
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a global (re)insurance company. It classify the business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.